Patent · US Expired

"Substituted N-acyl-N""-(3-amino-2-cyanoacryloyl-)formamidrazones"

US4051242A · kind A · utility

1Cited by
1References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 22, 1974
Grant dateSep 27, 1977
Priority date—
Expiry dateAug 22, 1994

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D295/145
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Therapeutically-active and pharmacologically-acceptable N-acyl-N" -(3-amino-2-cyanoacryloyl)-formamidrazones and their pharmaceutically-acceptable acid-addition salts inhibit xanthine oxidase and are useful as the active ingredient in medicaments for the treatment of gout.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.